Search
Cancel
Platform
Therapeutics
Therapeutics
Cell therapies
Pipeline
Partnerships
ioCells
ioCells
Discover ioCells
View all products >
View all protocols >
Custom ioCells Development
ioWild Type Cells
Glial cells
ioAstrocytes
ioMicroglia | Female
ioMicroglia | Male
ioOligodendrocyte-like cells
Muscle cells
ioSkeletal Myocytes
Nerve cells
ioGABAergic Neurons
ioGlutamatergic Neurons
ioMotor Neurons
ioSensory Neurons
ioDisease Model Cells
ALS and FTD
Alzheimer's disease
Duchenne Muscular Dystrophy
Huntington's disease
Parkinson's and Gaucher disease
Custom ioDisease Model Cells
CRISPR-Ready ioCells
CRISPR-Ready ioGlutamatergic Neurons
CRISPR-Ready ioMicroglia | Male
ioTracker Cells
GFP ioMicroglia Coming soon!
News and Events
News and Events
News
View all
Topics
Article
CEO views
New product
News
Podcast
Press release
Talk
Events
View all
Resources
Resources
Resources
View all
General resources
Application notes
bits of bio
Case studies
Infographics
Posters
Publications
Talks
Videos
Video tutorials
Webinars
Product information
Brochures
User manuals
Protocol library
View all
CNS co-culture
New! ioGlutamatergic Neurons | ioAstrocytes
ioGlutamatergic Neurons | ioMicroglia
CNS tri-culture MEA analysis
ioGlutamatergic Neurons | ioGABAergic Neurons | astrocytes
Cell culture and preparation
ioMicroglia cell detachment
Cell characterisation and assays
ioGABAergic Neurons ICC
ioGlutamatergic Neurons ICC
ioMicroglia cytokine release
ioOligodendrocyte-like cells ICC
ioSkeletal Myocytes ICC
Blog
View all articles
Browse topics
CEO views
Culture
Expert opinion
Science
Technology
Sustainability
About
About
Our company
About us
Leadership and Boards
Sustainability
Work with us
Partners
Careers
Careers
Working at bit.bio
Open roles
How we hire
Employee spotlights
Contact
Search
Rewriting human health,
one cell at a time
Biomedical innovation and a new generation of cures through deterministic cell programming
Cell coding platform
Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency.
Explore our platform
Therapeutics
Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.
Learn more
ioCells
Deterministically programmed human iPSC-derived cells for research and drug discovery
Discover ioCells
Latest news
Press Release
bit.bio Raises $30 Million Led by M&G Investments
16.12.2024
Published by bit.bio
Read now
News
Insights from iGEM Judge Andreas: Exploring Synthetic Biology, Innovation, and Future Bioengineers
17.10.2024
Published by bit.bio
Read now
Press Release
bit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell Programming Technology
16.10.2024
Published by bit.bio
Read now
Article
bit.bio featured in Tech Nation's Future Fifty Report
09.10.2024
Published by Tech Nation
Read now